ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,954.50
      1.59%
      US Tech 100
      20,332.80
      1.61%
      Dow Jones
      43,840.91
      1.39%
      Brent Oil
      73.045
      0.00%
      Bitcoin
      85,068.92
      0.83%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Sigilon Therapeutics Inc (SGTX)

      7. Sigilon Therapeutics Inc (SGTX) News

      Sigilon Therapeutics Inc

      Sigilon Therapeutics Inc (SGTX)

      NASDAQ
      22.47
      0.00
      (0.00%)
      Closed March 01 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      SGTX News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      July 27 2023
      SGTX (0.00%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      July 24 2023
      SGTX (0.00%)

      Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
      Edgar (US Regulatory)
      July 18 2023
      SGTX (0.00%)

      Form SC 14D9 - Solicitation, recommendation statements
      Edgar (US Regulatory)
      July 13 2023
      SGTX (0.00%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 29 2023
      SGTX (0.00%)

      SGTX Discussion

      View Posts
      Invest-in-America Invest-in-America 2 years ago
      He made NOTHING.
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      SGTX: Because NO ONE on the entire iHub PLATFORM owned any of this Firm's shares yesterday --- nor for months!!! (Including glorious Mr. EZBucks chap.) And THAT is why, Bro.
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      Hey, Admiral Scotty, Mr. EZ did NOT have even one share of this Beast --- since he "alerted it" MONTHS ago. (However, just imagine the Peeps that DID own this yesterday; and, when one reads the Lily DEAL, they gots lots MORE CASH coming, no matter how that Investigation goes down!!!!)

      PS: My 'CONGRATS' post to Mr. EZ was pure SARCASM!!! (I used to like that dude, but he's just jerk.)
      👍️0
      Invest-in-America Invest-in-America 2 years ago
      SGTX: Well, King EZ --- since you must have grabbed a huge chunk of this at a paltry $0.66 months ago --- you surely must have dumped it all today for well over ONE-MILLION-DOLLARS profit!!! WOW, Dude!!! MONSTER CONGRATS to ya, Emperor EZ!!!!!



      👍️0
      TIMGZ TIMGZ 2 years ago
      SGTX LIKE********THINKIN OF ***LXRX**WINT***GNPX****SLS***ORTX****PROBABLE ACQUISITION CANDIDATE. WHAT DO YOU THINK. THANKS
      👍️0
      TIMGZ TIMGZ 2 years ago
      I KNOW YOU ALAWYS SHARE, KINDLY DO NOT LEAVE US ON THE SIDELINE. THANK YOU ALWAYS
      👍️0
      Roadtojourney Roadtojourney 2 years ago
      This is huge news, why is no one talking about??
      👍️0
      BeamMeUpScotty BeamMeUpScotty 2 years ago
      Why don’t you set up an alert service? There are plenty you can use that all you need to do is charge a nominal sum and then you can alert your entries with any other comments you want to add in real time.
      👍️0
      MiamiGent MiamiGent 2 years ago
      SGTX "Nothing to see here"- already happened - but can marvel at :)

      SIGILON THERAPEUTICS INC
      $24.75 +20.82 (+529.77%)
      As of Jun-29-2023

      Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On
      by BENZINGA

      Sigilon Therapeutics Inc (NASDAQ:SGTX) shares are skyrocketing after Eli Lilly And Co (NYSE:LLY) agreed to acquire the company for a purchase price of $14.92 per share in cash (an aggregate of approximately $34.6 million).

      Sigilon is also entitled to one non-tradeable contingent value right ("CVR") per share to receive up to an additional $111.64 per share in cash, for a total potential consideration of up to $126.56 per share in cash without interest (an aggregate of up to approximately $309.6 million excluding shares held by Lilly).

      The transaction is not subject to any financing condition and is expected to close in the third quarter of 2023.

      Since 2018, Lilly and Sigilon have worked together to develop encapsulated cell therapies, including SIG-002, for type 1 diabetes.

      In the Q1 FY23 earnings release, Sigilon said its near-term focus is on development efforts for SIG-002, its product candidate for type 1 diabetes, which is being developed in collaboration with Eli Lilly.

      Sigilon initiated IND-enabling activities for SIG-002 and anticipates initiating non-human primate (NHP) studies in 2H 2023. Additionally, the company expects an IND submission for SIG-002 in 2024.
      👍️ 1
      makinezmoney makinezmoney 2 years ago
      $SGTX: Thanx dude.....................

      Appreciate the KIND words.


      Lots more to be made on the markets.......... got my eyes on more diamonds in the rough.

      This isn't the only one


      GO $SGTX
      👍️0
      TIMGZ TIMGZ 2 years ago
      MAKINEZ, HOPE YOU BANK BIG! CONGRATS

      DIAMOND IN A ROUGH COMES ONCE IN WHILE, THIS IS DEFINITELY ONE.
      DANCING TO THE BANK AND GOOD FOR THE PUBLIC TOO.
      NEW DRUG IS COMING TO THE MARKET PRETTY SOON
      👍️0
      makinezmoney makinezmoney 2 years ago
      $SGTX: Gave it to you at $0.66 .... NOW $36 !!!!!!!!!!!!!


      YEEEEEEEOWWwwwwwwwwwwwwwwwwwwwwwww...................... Y'all MAKIN EZ MONEY YET ???


      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171441550


      GO $SGTX
      👍️0
      tw0122 tw0122 2 years ago
      Hope you made some $$$
      👍️0
      Awl416 Awl416 2 years ago
      Lilly to Acquire Sigilon Therapeutics
      👍️0
      makinezmoney makinezmoney 2 years ago
      $SGTX: Killer intraday mover........... from $0.74..........

      And now $1.30 !!!!!!!!!!



      YEEEEEEEEeeeowwwwwwwwwwwwwwwwwwwww........................ I'm running out of POSTS..


      Where my loyal followers........... I've been giving you bangers lately,

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171438110


      Hook me up with a ONE YEAR iHUB sub amigos.


      GO $SGTX
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      sgtx the next bio to soar...1.25 coming here
      👍️0
      makinezmoney makinezmoney 2 years ago
      $SGTX: MarketCap only $11Milly.... Cash-on-HAND at $96Milly

      I would say this can go up another $2share from here for sure.


      Now at 0.66


      GO $SGTX
      👍️0
      makinezmoney makinezmoney 2 years ago
      $SGTX: Is it too late ?? now 0.70

      Wish I saw this a lil earlier.


      But nice pop there....................


      https://ir.sigilon.com/static-files/94cc6b3f-5656-497a-a9be-0e8b4d1c1b36


      GO $SGTX
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 2 years ago
      SGTX ON THE MOVE
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Sigilon Therapeutics, Inc., a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced the pricing of its upsized initial public offering of 7,000,000 shares of its common stock at a public offering price of $18.00 per share. All of the shares are being offered by Sigilon. In addition, Sigilon has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Sigilon’s common stock is expected to begin trading on the Nasdaq Global Market on December 4, 2020 under the symbol “SGTX.”
      The gross proceeds of the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Sigilon, are expected to be $126.0 million excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on December 8, 2020, subject to the satisfaction of customary closing conditions.
      👍️0
      crudeoil24 crudeoil24 4 years ago
      Sigilon Therapeutics Inc. is a clinical-stage biotechnology company seeking to develop functional cures for patients with chronic diseases by providing stable and durable levels of therapeutic molecules to patients. The Company has developed its SLTx platform, which combines advanced cell engineering with advancements in biocompatible materials and enables its product candidates to produce a wide range of therapeutic molecules that may be missing or deficient, such as proteins, antibodies and enzymes. The Company’s lead product candidate is SIG-001, which is designed to prevent bleeding episodes in patients with moderate-severe to severe Hemophilia. The Company’s other product candidates includes SIG-009, SIG-003, SIG-005, SIG-007, SIG-018, SIG-002, SIG-014 and SIG-015.
      👍️0
      crudeoil24 crudeoil24 4 years ago
      IPO > closing price > 34.78
      👍️0

      Your Recent History

      NASDAQ
      SGTX
      Sigilon Therapeutics
      TSXV
      CXD.P
      Chainode Opportunities
      AMEX
      DIG
      ProShares Ultra Energy
      TSXV
      KAPA.P
      Kapa Capital
      NYSE
      NEM
      Newmont
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads